ProShares Ultra Nasdaq Biotechnology (BIB) Holdings → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free BIB Stock Alerts $56.09 +0.48 (+0.86%) (As of 05/31/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Top 50 BIB HoldingsRankCompanyCurrent PriceWeightShares Held1NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGN/A47.75%9,6272NASDAQ BIO INDEX SWAP BNPN/A36.67%7,3943NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAN/A19.31%3,8934NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEN/A11.54%2,3275NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONALN/A6.55%1,3216AMGNAmgen$305.85+1.6%6.28%18,258 Get the Latest News and Ratings for BIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 7VRTXVertex Pharmaceuticals$455.34+2.8%6.02%11,8838NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAN/A5.96%1,2029REGNRegeneron Pharmaceuticals$980.16+1.1%5.70%5,17610GILDGilead Sciences$64.27+0.3%5.15%69,34011MRNAModerna$142.55-5.9%4.49%24,38712NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLCN/A3.39%68313AZNAstraZeneca$78.02+1.6%3.26%37,16414BIIBBiogen$224.94+2.2%2.27%9,27715ALNYAlnylam Pharmaceuticals$148.43-1.1%1.35%8,03916ILMNIllumina$104.28+3.2%1.21%10,14017BMRNBioMarin Pharmaceutical$75.07+0.8%1.03%12,03918NBIXNeurocrine Biosciences$135.41-0.9%1.00%6,35419SNYSanofi$49.03+2.5%0.96%17,48320UTHRUnited Therapeutics$275.13+1.7%0.93%3,00521INCYIncyte$57.79+0.9%0.92%14,33322VTRSViatris$10.60+1.1%0.90%75,79223MEDPMedpace$386.34+0.2%0.86%1,96424RPRXRoyalty Pharma$27.41+3.9%0.86%28,51125SRPTSarepta Therapeutics$129.86+4.3%0.86%5,99126ARGXargenx$371.02+2.4%0.80%1,98527BNTXBioNTech$100.60+1.9%0.69%6,17828ROIVRoivant Sciences$10.36-0.3%0.63%51,43129PCVXVaxcyte$70.27+0.1%0.54%6,91630ASNDAscendis Pharma A/S$135.10-1.7%0.53%3,66731BGNEBeiGene$148.85-3.5%0.46%2,64332ITCIIntra-Cellular Therapies$67.24+2.4%0.46%6,18233JAZZJazz Pharmaceuticals$105.25-0.2%0.46%3,97834BPMCBlueprint Medicines$105.56-0.8%0.45%3,90935RVMDRevolution Medicines$38.33+0.4%0.45%10,51336EXELExelixis$21.69+4.4%0.44%19,35337HALOHalozyme Therapeutics$44.29+2.2%0.40%8,09238IONSIonis Pharmaceuticals$37.57+2.8%0.40%9,30539CYTKCytokinetics$48.51-1.2%0.36%6,57040BBIOBridgeBio Pharma$28.01-2.9%0.35%11,221Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE.41APLSApellis Pharmaceuticals$39.25-3.7%0.34%7,69942MDGLMadrigal Pharmaceuticals$236.16+4.7%0.34%1,27243KRYSKrystal Biotech$160.05-1.0%0.33%1,80344CRSPCRISPR Therapeutics$53.74-0.6%0.32%5,12445IBRXImmunityBio$6.42-2.9%0.32%42,61346IMVTImmunovant$25.39-3.9%0.30%9,27247ALKSAlkermes$23.40+0.8%0.29%10,66348NUVLNuvalent$65.62-1.3%0.28%3,74449AXSMAxsome Therapeutics$73.43-1.1%0.25%3,02250INSMInsmed$55.05-3.4%0.25%9,475 Geographic ExposureUnited States82.8%Ireland0.8%Bermuda0.6%Canada0.5%Switzerland0.3%Netherlands0.3%Jersey0.2%Singapore0.1%Currency ExposureUSD92.2%Sector ExposureHealth Care57.2%Consumer Discretionary0.6%Energy0.2%Industry ExposureBiotechnology53.1%Health Care Equipment & Supplies1.9%Diversified Consumer Services1.1%Pharmaceuticals0.5%Distributors0.4%Renewable Energy0.2%SubIndustry ExposureBiotechnology51.3%Life Sciences Tools & Services2.5%Pharmaceuticals1.1%Health Care Equipment0.2%Renewable Energy Equipment0.2% Related Companies and Tools Related Companies: Invesco Dorsey Wright Healthcare Momentum ETF Top Holdings Principal Healthcare Innovators ETF Top Holdings Invesco Nasdaq Biotechnology ETF Top Holdings First Trust Nasdaq Pharmaceuticals ETF Top Holdings Horizon Kinetics Medical ETF Top Holdings JPMorgan Healthcare Leaders ETF Top Holdings ProShares UltraShort Nasdaq Biotechnology Top Holdings Invesco S&P SmallCap Health Care ETF Top Holdings VanEck Biotech ETF Top Holdings VanEck Pharmaceutical ETF Top Holdings This page (NASDAQ:BIB) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss Ratings“This will be one of the biggest revolutions ever.” - NVIDIA CEOBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
